Current Employment Position(s)

Partner

Lawyer Overview

Dr. Coruzzi chairs the Firm's life sciences practices, which includes biotechnology, pharmaceuticals, medical devices, and diagnostics. Prior to joining Jones Day, she worked at Pennie & Edmonds LLP from 1981 through 2003 and was one of the first members of that firm's biotechnology group founded by S. Leslie Misrock, affectionately known as the "father of biotechnology patent law." Concentrating on intellectual property issues as applied to a variety of disciplines in the biotechnological field, Dr. Coruzzi's practice has evolved with the patent laws and matured with the needs of the biotechnology/pharmaceutical industries. Her current practice involves all aspects of patent law as it relates to the emerging fields of biotechnology, including genetic engineering, molecular biology, plant molecular biology, virology, immunology, genomics, functional genomics, proteomics, diagnostics, drug discovery, pharmaceuticals, pharmacogenomics, and drug delivery.

The focus of Dr. Coruzzi's patent procurement practice centers on the strategic planning and management of patent portfolios designed to protect emerging new platform technologies (such as functional genomics, proteomics, tissue engineering, and gene therapy), biologics (antibodies, growth factors, and peptide drugs), as well as other pharmaceuticals and therapies (antivirals, anti-angiogenic therapies, and chemotherapeutics). This includes handling U.S. prosecution and interference as well as management of corresponding foreign proceedings, particularly oppositions in the European Patent Office and Australia and revocations and litigations in the United Kingdom. Her client counseling activities include due diligence evaluations of patent portfolios; evaluation, analysis, and opinions on the patentability of inventions; validity of patents and freedom-to-operate or clearance opinions; and involvement in licensing strategies, negotiations, and agreements.

In addition to procurement and counseling, Dr. Coruzzi's practice also encompasses litigation and an appellate practice (at the Board of Patent Appeals and Interferences and the Court of Appeals for the Federal Court). Her litigation practice includes the development of trial strategy and participation in discovery, with extensive involvement in preparation of expert witnesses in technologies involving genetic engineering, molecular biology, drug screening, and pharmaceuticals. Most recently, in an appeal she argued at the Court of Appeals for the Federal Circuit, Dr. Coruzzi and her team at Pennie & Edmonds won a reversal of a jury verdict and invalidated a patent covering cell-based assays for drug screening in Sibia Neurosciences Inc. v. Cadus Pharmaceutical Corporation, 225 F.3d 1349 (Fed. Cir. 2000).

Dr. Coruzzi is a frequent invited speaker at symposia on patent law issues related to cloning, genomics, ESTs (expressed sequence tags), SNPs (single nucleotide polymorphisms), and gene therapy. She is a member of the New York State Bar Association, the American Intellectual Property Law Association, the New York Intellectual Property Law Association, and the American Association for the Advancement of Science. She is also a member of the Metropolitan Opera Guild, The Metropolitan Museum of Art, the Museum of Modern Art, and the American Museum of Natural History.

Areas of Practice

• Intellectual Property
• Patent Litigation
• Patent Prosecution
• Federal Circuit and IP Appeals
• Life Sciences
• Pharmaceuticals

Representative Cases

• epicRealm Licensing, LP v. Franklin Covey Co., (2:05-CV-356)
• Bristol-Myers Squibb Company v. Erbamont, Inc., Farmitalia Carlo Erba, S.r.l., and Erbamont, N.V.
• Genzyme Corporation and Mount Sinai School of Medicine v. Transkaryotic Therapies, Inc., No. 00-677-GMS, 2001 WL 1530375 (D. Del); 346 F.3d 1094 (Fed. Cir. 2004)
• Herbalife International, Inc. v. Unither Pharma, Inc., Case No. CO3-5878 (JW) and CO3-5090 (JW) (N.D. Cal. 2004)
• In the Matter of Certain Doxorubicin and Preparations Containing Same
• SIBIA Neurosciences, Inc. v. Cadus Pharmaceutical Corporation, 225 F.3d 1349 (Fed. Cir. 2000)
• The Liposome Company, Inc. v. Vestar, Inc.
• The Standard Oil Company v. Nippon Shukubai Kagaku Kogyo Co. Ltd.
• Patent Prosecution
• Patent Prosecution
• Patent Prosecution
• Patent Prosecution
• Patent Prosecution and Defense
• Patent Prosecution and Portfolio
• Patent Prosecution and Portfolio
• Patent Prosecution and Portfolio
• Patent Prosecution and Portfolio
• Patent Prosecution and Portfolio
• Patent Prosecution and Portfolio
• Patent Prosecution and Portfolio
• Patent Prosecution and Portfolio Management

West Practice Categories

Copyrights, Federal Appellate Practice, Federal Trial Practice, Intellectual Property Law, International Intellectual Property, Patent Litigation, Patents, State Trial Practice, Technology Licensing, Trade Dress, Trade Secrets, Trademarks, US Court of Appeals for the Federal Circuit, US Supreme Court

Bar Admissions

• New York, First Department

Education

• Fordham University

Published Works

• Outstanding Women: Laura Coruzzi, IP Law360, 2007
• Jones Day's Intellectual Property Practice, 2006
• Intellectual Property: Petition for Certiorari Filed in AWH Corp. v. Phillips, 2005
• Winning Legal Strategies for Biotech Companies: Intellectual Property Protection, FDA Approval, and Board Management for the Biotech Industry (Inside the Minds), coauthor, Aspatore Books, Legal Strategies for Biotechnology Companies, 2005
• Intellectual Property: The Supreme Court Widens the Range of Permissible Preclinical Studies Under the § 271(e)(1) Safe Harbor For Patent Infringement —But How Much?, 2005

Address

222 East 41st Street
New York, NY 10017-6702

Phones

1.212.326.8383 (Business Phone)

Faxes

1.212.755.7306 (Business Fax)

Emails

Contact Us (Business Email)

Websites

http://www.jonesday.com